At a glance
- Originator Chiesi
- Class Heart failure therapies
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 20 May 1998 Discontinued-Preclinical for Congestive heart failure in Italy (Unknown route)
- 03 Sep 1997 New profile
- 03 Sep 1997 Preclinical development for Congestive heart failure in Italy (Unknown route)